Waverley Pharma (TSXV:WAVE) Institutional Ownership : 2.53% (As of Mar. 04, 2025)

View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Waverley Pharma's institutional ownership is 2.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Waverley Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Waverley Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Waverley Pharma Institutional Ownership Historical Data

The historical data trend for Waverley Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Institutional Ownership Chart

Waverley Pharma Historical Data

The historical data trend for Waverley Pharma can be seen below:

	2019-09-30	2019-10-31	2019-12-31	2020-01-31	2020-02-29	2020-03-31	2020-04-30	2020-05-31	2020-06-30	2020-07-31
Institutional Ownership	7.41	7.41	7.41	7.41	7.41	7.41	7.40	7.40	7.40	2.53

Waverley Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Waverley Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

5GZ:Germany

Address

1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.waverleypharma.com

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Bortezomib, Pemetrexed, Capecitabine, and Temozolomide, among others.

Executives